COST-EFFECTIVENESS AND BUDGET IMPACT OF INTERFERON-FREE DIRECT-ACTING ANTIVIRAL (DAA)-BASED REGIMENS FOR CHRONIC HEPATITIS C TREATMENT. THE FRENCH CASE

被引：0
|
作者：
Deuffic-Burban, S. [1 ,2 ]
Obach, D. [1 ]
Canva, V. [3 ]
Pol, S. [4 ,5 ]
Roudot-Thoraval, F. [6 ]
Dhumeaux, D. [7 ]
Mathurin, P. [2 ,3 ]
Yazdanpanah, Y. [1 ,8 ]
机构：
[1] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, IAME,UMR 1137, Paris, France
[2] Univ Lille, INSERM, Lille Inflammat Res Int, CHU Lille,LIRIC,U995, Villeneuve Dascq, France
[3] CHRU Lille, Hop Huriez, Serv Malad Appareil Digestif & Nutr, Lille, France
[4] Grp Hosp Cochin Hotel Dieu, Unite Hepatol, Paris, France
[5] Univ Paris 05, INSERM, U1016, Paris, France
[6] Hop Henri Mondor, Serv Sante Publ, Creteil, France
[7] Hop Henri Mondor, INSERM, U955, Creteil, France
[8] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00793-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-434
引用
收藏
页码：S470 / S471
页数：2
相关论文
共 50 条
  • [31] Direct-acting antivirals for hepatitis C treatment: effectiveness versus cost-effectiveness
    Chhatwal, Jagpreet
    FUTURE VIROLOGY, 2015, 10 (08) : 929 - 932
  • [32] Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus Infection
    Liu, Chen-Hua
    Chen, Yih-Sharng
    Wang, Sheoi-Shen
    Liu, Chun-Jen
    Su, Tung-Hung
    Yang, Hung-Chih
    Hong, Chun-Ming
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (02) : 289 - 292
  • [33] Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia
    Ji, F.
    Wei, B.
    Yeo, Y. H.
    Ogawa, E.
    Zou, B.
    Stave, C. D.
    Li, Z.
    Dang, S.
    Furusyo, N.
    Cheung, R. C.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 550 - 562
  • [34] All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses
    Hagan, L. M.
    Yang, Z.
    Ehteshami, M.
    Schinazi, R. F.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (12) : 847 - 857
  • [35] Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials
    Harrington, Patrick R.
    Deming, Damon J.
    Komatsu, Takashi E.
    Naeger, Lisa K.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (04) : 666 - 667
  • [36] Cost and cost-effectiveness of a simplified treatment model with direct-acting antivirals for chronic hepatitis C in Cambodia
    Walker, Josephine G.
    Mafirakureva, Nyashadzaishe
    Iwamoto, Momoko
    Campbell, Linda
    San Kim, Chamroeun
    Hastings, Reuben A.
    Doussett, Jean-Philippe
    Le Paih, Mickael
    Balkan, Suna
    Marquardt, Tonia
    Maman, David
    Loarec, Anne
    Coast, Joanna
    Vickerman, Peter
    LIVER INTERNATIONAL, 2020, 40 (10) : 2356 - 2366
  • [37] Direct-Acting Antiviral Drugs for the Treatment of Chronic Hepatitis C Virus Infection: Interferon Free Is Now
    Florian, J.
    Mishra, P.
    Arya, V.
    Harrington, P.
    Connelly, S.
    Reynolds, K. S.
    Sinha, V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (04) : 394 - 402
  • [38] Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
    Liu, Chen-Hua
    Liu, Chun-Jen
    Su, Tung-Hung
    Fang, Yu-Jen
    Yang, Hung-Chih
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [39] The cost-effectiveness of novel direct acting antiviral agent therapies for the treatment of chronic hepatitis C
    Bickerstaff, Cherrishe
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (05) : 787 - 800
  • [40] AUTOIMMUNE SYNDROMES WITH CHRONIC HEPATITIS C VIRUS INFECTION AND DIRECT-ACTING ANTIVIRAL TREATMENT.
    Mohammed, R. H. A.
    Attia, D. Hassan
    Abdelazeem, M.
    Taha, A. Elsayed
    Bahgat, D. Rasheed
    Elmakhzangy, H. Ibrahim I.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 918 - 918
12345